Kura Oncology Inc’s recent filing unveils that its Chief Legal Officer Bair Teresa Brophy unloaded Company’s shares for reported $9292.0 on May 19 ’25. In the deal valued at $5.96 per share,1,559 shares were sold. As a result of this transaction, Bair Teresa Brophy now holds 107,948 shares worth roughly $0.67 million.
Then, FORD KATHLEEN sold 1,558 shares, generating $9,777 in total proceeds. Upon selling the shares at $6.28, the Chief Operating Officer now owns 21,367 shares.
Before that, FORD KATHLEEN bought 1,558 shares. Kura Oncology Inc shares valued at $9,286 were divested by the Officer at a price of $5.96 per share.
BTIG Research downgraded its Kura Oncology Inc [KURA] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Stifel also remained covering KURA and has decreased its forecast on October 14, 2024 with a “Hold” recommendation from previously “Buy” rating. Mizuho started covering the stock on December 22, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Monday, Kura Oncology Inc [NASDAQ:KURA] saw its stock jump 3.65% to $6.24. Over the last five days, the stock has gained 2.46%. Kura Oncology Inc shares have fallen nearly -28.36% since the year began. Nevertheless, the stocks have fallen -71.47% over the past one year.
How much short interest is there in Kura Oncology Inc?
A steep rise in short interest was recorded in Kura Oncology Inc stocks on 2025-04-30, dropping by -0.52 million shares to a total of 8.28 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 8.8 million shares. There was a decline of -6.27%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on August 11, 2023 when BofA Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $31 price target.
